Victoza's Regulatory Limbo Could End Shortly  

FDA will provide "formal feedback" to Novo Nordisk "within weeks" about its type 2 diabetes drug, which showed a thyroid cancer signal in rodents.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet